29W05: Abstracts: Systemic Sclerosis & Related Disorders – Clinical III (2651–2656)

Abstract Moderator(s)

• 

  Antonia Valenzuela, MD, MS

  Pontificia Universidad Catolica de Chile
  Santiago, Chile

  Disclosure information not submitted.
• MO

  Mohammed Osman, MD, PhD, BSc

  University of Alberta
  Edmonton, Alberta, Canada

  Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

• 9:30 AM - 9:45 AM Central Time

  Development and Validation of the Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement
  

  Presenting Author: Laura Ross, MBBS PhD FRACP – The University of Melbourne
• 9:45 AM - 10:00 AM Central Time

  Anti-mitochondrial Antibodies in Systemic Sclerosis Target Enteric Neurons and Are Associated with GI Dysmotility
  

  Presenting Author: Subhash Kulkarni, PhD – BIDMC
• 10:00 AM - 10:15 AM Central Time

  First Prospective Evaluation of Recombinant Herpes Zoster Vaccine in Systemic Sclerosis: Immunogenicity, Safety, and Disease Activity Outcomes
  

  Presenting Author: ANA PAULA LUPPINO-ASSAD, MD, PhD – Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)
• 10:15 AM - 10:30 AM Central Time

  Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
  

  Presenting Author: Ellen Romich, MD, MSCE – University of Pennsylvania
• 10:30 AM - 10:45 AM Central Time

  Fetal and maternal outcomes in systemic sclerosis and very early diagnosis of systemic sclerosis pregnancies, a national prospective study
  

  Presenting Author: Anne Murarasu, MD – Ecole doctorale Pierre Louis de Santé Publique
• 10:45 AM - 11:00 AM Central Time

  Long-term effect of selexipag in systemic sclerosis-associated digital ulcers: a case control, multicentre, observational study
  

  Presenting Author: Claudia Iannone, MD – University of Milan, Gaetano Pini CTO